Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey

被引:430
作者
Cleland, JGF [1 ]
Cohen-Solal, A
Aguilar, JC
Dietz, R
Eastaugh, J
Follath, F
Freemantle, N
Gavazzi, A
van Gilst, WH
Hobbs, FDR
Korewicki, J
Madeira, HC
Preda, I
Swedberg, K
Widimsky, J
机构
[1] Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England
[2] Hop Beaujon, Dept Cardiol, Clichy, France
[3] Hosp La Fe, E-46009 Valencia, Spain
[4] Humboldt Univ, Max Delbruck Centrum, Franz Volhard Klin, Berlin, Germany
[5] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England
[6] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[7] Osped Riuniti Bergamo, Unita Operat Cardiol, Dipartimento Cardiovasc, I-24100 Bergamo, Italy
[8] Univ Groningen, Dept Clin Pharmacol, Groningen, Netherlands
[9] Natl Inst Cardiol, Warsaw, Poland
[10] Fac Med Lisbon, Cadeira Med 3, Lisbon, Portugal
[11] Semmelweis Univ, Dept Cardiol & Internal Med, Budapest, Hungary
[12] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden
[13] Postgrad Med Sch, Dept Cardiol, Prague, Czech Republic
关键词
D O I
10.1016/S0140-6736(02)11601-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Heart failure is a prevalent condition that is generally treated in primary care. The aim of this study was to assess how primary-care physicians think that heart failure should be managed, how they implement their knowledge, and whether differences exist in practice between countries. Methods The survey was undertaken in 15 countries that had membership of the European Society of Cardiology (ESC) between Sept 1, 1999, and May 31, 2000. Primary-care physicians' knowledge and perceptions about the management of heart failure were assessed with a perception survey and how a representative sample of patients was managed with an actual practice survey. Findings 1363 physicians provided data for 11062 patients, of whom 54% were older than 70 years and 45% were women. 82% of patients had had an echocardiogram but only 51% of these showed left ventricular systolic dysfunction. Ischaemic heart disease, hypertension, diabetes mellitus, atrial fibrillation, and major valve disease were all common. Physicians gave roughly equal priority to improvement of symptoms and prognosis. Most were aware of the benefits of ACE inhibitors and beta blockers. 60% of patients were prescribed ACE inhibitors, 34% beta blockers but only 20% received these drugs in combination. Doses given. were about 50% of targets suggested in the ESC guidelines. If systolic dysfunction was documented, ACE inhibitors were more likely and beta blockers less likely to be prescribed than when there was no evidence of systolic dysfunction. Interpretation Results from this survey suggest that most patients with heart failure are appropriately investigated, although this finding might be as a result of high rates of hospital admissions. However, treatment seems to be less than optimum, and there are substantial variations in practice between countries. The inconsistencies between physicians' knowledge and the treatment that they deliver suggests that improved organisation of care for heart failure is required.
引用
收藏
页码:1631 / 1639
页数:9
相关论文
共 33 条
  • [1] Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study
    Caruana, L
    Petrie, MC
    Davie, AP
    McMurray, JJV
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7255) : 215 - 218
  • [2] Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: comparison with radionuclide ventriculography and echocardiography
    Clark, AL
    Coats, AJS
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (895) : 289 - 291
  • [3] SEVERITY OF HEART-FAILURE AND DOSAGE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    CLARK, AL
    COATS, AJS
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6985) : 973 - 974
  • [4] CLELAND JG, 1995, EUR HEART J, V16, P741
  • [5] Perindopril for elderly people with chronic heart failure: the PEP-CHF study
    Cleland, JGF
    Tendera, M
    Adamus, J
    Freemantle, N
    Gray, CS
    Lye, M
    O'Mahony, D
    Polonski, L
    Taylor, J
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) : 211 - 217
  • [6] The evidence for β blockers in heart failure -: Equals or surpasses that for angiotensin converting enzyme inhibitors
    Cleland, JGF
    McGowan, J
    Clark, A
    Freemantle, N
    [J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7187) : 824 - 825
  • [7] Cleland JGF, 1998, LANCET, V352, P19
  • [8] Cleland JGF, 1999, J CARDIOVASC RISK, V6, P131
  • [9] The heart failure epidemic: exactly how big is it?
    Cleland, JGF
    Khand, A
    Clark, A
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (08) : 623 - 626
  • [10] Progression from hypertension to heart failure - Mechanisms and management
    Cleland, JGF
    [J]. CARDIOLOGY, 1999, 92 : 10 - 19